August 07, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Kidney, CV benefits of GLP-1s, SGLT2 inhibitors may vary by kidney failure risk
Kidney failure risk may impact treatment effectiveness of SGLT2 inhibitors vs. GLP-1 drugs for veterans with type 2 diabetes, according to study data published in the Journal of the American Society of Nephrology. Currently, no randomized controlled trials have compared the effectiveness of SGLT2 inhibitors vs. non-exendin GLP-1 receptor agonists, according to Srinivasan Beddhu, MD, scientific
971 words~4 min read
